Candel Therapeutics, Inc. (CADL) Operating Lease, Payments USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Candel Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to 2024.
  • Candel Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $148 K, a 2.78% increase year-over-year.
  • Candel Therapeutics, Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $587 K, a 2.98% increase year-over-year.
  • Candel Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $583 K, a 2.82% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $587 K $148 K +$4 K +2.78% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $583 K $239 K +$54 K +29.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $529 K $100 K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $529 K $100 K -$41 K -29.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $570 K $144 K +$3 K +2.13% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $567 K $185 K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $100 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $141 K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $141 K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.